To this end, we applied single-cell RNA sequencing (scRNA-seq) on CD45+ cells within the TME to characterize immune cell responses during cSCC progression, since scRNA-seq is a key method to comprehensively characterize the intra-tumoral heterogeneity within many cancer types [13,14,15]. The gene discussed is PTPRC; the disease is cancer.